Given that dysregulated kinase activity, particularly with tau as the substrate, is a defining feature of tauopathies[69], these experiments will assist in better defining the role of disrupted neuronal-glial interactions in tauopathy pathogenesis. This evidence concerns the gene MAPT and tauopathy.